Concepedia

Histopathological and Epigenetic Changes in Myocardium Associated with Cancer Therapy-Related Cardiac Dysfunction

Chiyoko‐Ikeda Terada, Kenji Onoue, Tomomi Fujii, Hiroe Itami, Kohei Morita, Tomoko Uchiyama, Maiko Takeda, Hitoshi Nakagawa, Tomoya Nakano, Youichirou Baba,

ESC Heart Failure · 2022 · 13 citations · 23 references

DOIFull text

Open access

Abstract

Our results indicate distinct morphological characteristics in myocardial histopathology associated with CTRCD. p53 and H3K27ac histone modification could be sensitive markers of CTRCD and suggest a mechanistic involvement of epigenetic changes.

References

23

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz et al. · European Heart Journal · 2016 · 2.5K citations · Full text

2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines

José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz et al. · European Journal of Heart Failure · 2016 · 1.8K citations · Full text

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

Daniela Cardinale, Alessandro Colombo, Giulia Bacchiani et al. · Circulation · 2015 · 1.6K citations

eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription

Carlos A. Melo, Jarno Drost, Patrick J. Wijchers et al. · Molecular Cell · 2012 · 520 citations · Full text

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

Amanda Varnava · Heart · 2000 · 440 citations · Full text